PATENT CLAIM ANALYSIS

Application Number: 15905711
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "174100"]

Abstract:
The present invention relates to the field of molecular biology and cancer biology. Specifically, the present invention relates to methods of treating a subject with a farnesyltransferase inhibitor (FTI) that include determining whether the subject is likely to be responsive to the FTI treatment based on genotyping and expression profiling of certain immunological genes and RAS mutation status in the subject.

Claim (Index 1):
A method of treating a H-Ras mutant non-small cell lung carcinoma in a subject, comprising administering a therapeutically effective amount of tipifarnib to said subject.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 88.0
- Lexical Diversity: 1.43478
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15346675', '15844478', '15238458', '15820012', '15820157']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8171682473286493
- 35 USC 102 Novelty (BERT): 0.6604762080314778
- Combined Prediction Score: 0.8014990433989322
- Mean Citation Score: 582.25276
- Max Citation Score: 745.21075
- Similarity Product: 614.2296429139973

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test